STOCK TITAN

STERIS executive Julia Madsen sells 2,046 shares

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

STERIS plc’s Sr. VP and GM, Life Sciences, Julia Madsen, sold 2,046 ordinary shares on November 13, 2026, at $260 per share. She directly held 10,211 ordinary shares after the sale. No Rule 10b5-1 plan is reported. Of her post-sale shares, 4,190 were restricted as of November 13, 2026.

Insider Madsen Julia
Role Sr. VP and GM, Life Sciences
Sold 2,046 shs ($532K)
Type Security Shares Price Value
Sale Ordinary Shares F1 2,046 $260.00 $532K
Holdings After Transaction: Ordinary Shares — 10,211 shares (Direct)
Footnotes (1)
  1. F1. As of November 13, 2026, 4,190 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 772 on June 2, 2027; 666 on June 3, 2027; 542 on June 4, 2027; 772 on June 2, 2028; 666 on June 5, 2028 and 772 on June 4, 2029.
Ordinary shares sold 2,046 shares Julia Madsen’s sale on November 13, 2026
Sale price $260 per share Julia Madsen’s sale on November 13, 2026
Direct holdings after sale 10,211 ordinary shares Julia Madsen’s reported post-sale position
Restricted ordinary shares 4,190 shares As of November 13, 2026
restricted financial
"4,190 of these ordinary shares are restricted"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many STERIS (STE) shares did Julia Madsen sell, and at what price?

Julia Madsen sold 2,046 STERIS plc ordinary shares at $260 per share on November 13, 2026. She directly held 10,211 ordinary shares after the sale, and no Rule 10b5-1 plan is reported.

When do restrictions on Julia Madsen’s restricted STERIS (STE) shares lapse?

Restrictions on 4,190 ordinary shares lapse as follows: 772 on June 2, 2027; 666 on June 3, 2027; 542 on June 4, 2027; 772 on June 2, 2028; 666 on June 5, 2028; and 772 on June 4, 2029.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Madsen Julia

(Last)(First)(Middle)
70 SIR JOHN ROGERSON'S QUAY

(Street)
DUBLIN 2D02 R296

(City)(State)(Zip)

IRELAND

(Country)
2. Issuer Name and Ticker or Trading Symbol
STERIS plc [ STE ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Sr. VP and GM, Life Sciences
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
11/13/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Ordinary Shares11/13/2026S2,046D$26010,211(1)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. As of November 13, 2026, 4,190 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 772 on June 2, 2027; 666 on June 3, 2027; 542 on June 4, 2027; 772 on June 2, 2028; 666 on June 5, 2028 and 772 on June 4, 2029.
Remarks:
/s/ John P. Ubbing, Authorized Representative under Power of Attorney11/17/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading